Infección por Enterovirus y parechovirus en niños

Referencias

1. Tapparel C, Siegrist F, Petty TJ, Kaiser L (2013) Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol. Doi: 10.1016/j.meegid.2012.10.016.
2. Hyypia T, Hovi T, Knowles NJ, Stanway G (1997) Classification of enteroviruses based on molecular and biological properties. J Gen Virol. Doi: 10.1099/0022-1317-78-1-1.
3. Dalldorf G, Sickles GM (1948) An unidentified, filtrable agent isolated from the feces of children with paralysis. Science 108:61
4. Crowell RL, Landau BJ (1997) A short history and introductory background on the coxsackieviruses of group B. Curr Top Microbiol Immunol 233:1
5. ENTERIC cytopathogenic human orphan (ECHO) viruses(1955). Science; 122:1187
6. Grist NR, Bell EJ, Assaad F, Grist NR, Bell EJ, Assaad F (1978) Enteroviruses in human disease. Prog Med Virol 24:114
7. Poyry T, Kinnunen L, Hyypia T, Brown B, Horsnell C, Hovi T, Stanway G (1996) Genetic and phylogenetic clustering of enteroviruses. J Gen Virol. Doi: 10.1099/0022-1317-77-8-1699.
8. Wigand R, Sabin AB (1961) Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch 11:224
9. Hyypia T, Horsnell C, Maaronen M, Khan M, Kalkkinen N, Auvinen P, Kinnunen L, Stanway G (1992) A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A 89:8847
10. Stanway G, Hyypia T (1999) Parechoviruses. J Virol 73:5249 11. Stanway G, Kalkkinen N, Roivainen M, Ghazi F, Khan M, Smyth M, Meurman O, Hyypia T (1994) Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol 68:8232
12. Www.picornaviridae.com
13. http://www.ictvonline.org/virusTaxonomy.asp
14. ICTV Master species list 2014 version 4. http://talk.ictvonline.org/files/ictv_documents/m/msl/5208.aspx
15. Khetsuriani N, Lamonte A, Oberste MS, Pallansch M (2006) Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003. Pediatr Infect Dis J. doi: 10.1097/01.inf.0000237798.07462.32
16. Rittichier KR, Bryan PA, Bassett KE, Taggart EW, Enriquez FR, Hillyard DR, Byington CL (2005) Diagnosis and outcomes of enterovirus infections in young infants. Pediatr Infect Dis J 24:546
17. SawyerMH (2002) Enterovirus infections: diagnosis and treatment. Semin Pediatr Infect Dis 13:40
18. Verboon-Maciolek MA, Krediet TG, van Loon AM, Kaan J, Galama JM, Gerards LJ, Fleer A (2002) Epidemiological survey of neonatal non-polio enterovirus infection in the Netherlands. J
Med Virol 66:241
19. Witso E, Palacios G, Cinek O, Stene LC, Grinde B, Janowitz D, Lipkin WI, Ronningen KS (2006) High prevalence of human enterovirus a infections in natural circulation of human enteroviruses.
J Clin Microbiol 44:4095
20. Byington CL, Taggart EW, Carroll KC, Hillyard DR (1999) A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile
infants 90 days and younger. Pediatrics 103:E27
21. Lee BE, Chawla R, Langley JM, Forgie SE, Al-Hosni M, Baerg K, Husain E, Strong J, Robinson JL, Allen U, Law BJ, Dobson S, Davies HD (2006) Paediatric Investigators Collaborative Network
on Infections in Canada (PICNIC) study of aseptic meningitis. BMC Infect Dis 6:68
22. Benschop K, Thomas X, Serpenti C, Molenkamp R, Wolthers K (2008) High prevalence of human Parechovirus (HPeV) genotypes in the Amsterdam region and identification of specific HPeV variants by direct genotyping of stool samples. J Clin Microbiol. doi: 10.1128/JCM.01379-08.
23. Harvala H, Wolthers KC, Simmonds P (2010) Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis 23:224
24. Joki-Korpela P, Hyypia T (1998) Diagnosis and epidemiology of echovirus 22 infections. Clin Infect Dis 27:129 25. Tauriainen S, Martiskainen M, Oikarinen S, Lonnrot M, Viskari H, Ilonen J, Simell O, Knip M, Hyoty H (2007) Human parechovirus 1infections in young children–no association with type 1 diabetes. J Med Virol. Doi: 10.1002/jmv.20831.
26. Khatami A, McMullan BJ, Webber M, Stewart P, Francis S, Timmers KJ, Rodas E, Druce J, Mehta B, Sloggett NA, Cumming G, Papadakis G, Kesson AM (2015) Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia. Clin Infect Dis. doi: 10.1093/cid/ciu784.
27. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and Prevention (2006) Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ
55(8):1–20
28. Esposito S, Rahamat-Langendoen J, Ascolese B, Senatore L, Castellazzi L, Niesters HG (2014) Pediatric parechovirus infections. J Clin Virol. Doi: 10.1016/j.jcv.2014.03.003.
29. Palacios G, ObersteMS (2005) Enteroviruses as agents of emerging infectious diseases. J Neurovirol 11:424
30. Bendig JW, Franklin OM, Hebden AK, Backhouse PJ, Clewley JP, Goldman AP, Piggott N (2003) Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J Med Virol. Doi: 10.1002/jmv.10437.
31. Konstantinidou A, Anninos H, Spanakis N, Kotsiakis X, Syridou G, Tsakris A, Patsouris E (2007) Transplacental infection of Coxsackievirus B3 pathological findings in the fetus. J Med Virol.
doi:10.1002/jmv.20887.
32. Rotbart HA (2000) Viral meningitis. Semin Neurol. doi: 10.1055/s-2000-9427.
33. Harvala H, Simmonds P (2009) Human Parechoviruses: biology, epidemiology and clinical significance. J Clin Virol. Doi: 10.1016/j.jcv.2009.03.009.
34. Long S, Pickering LK, Prober CG (2003) Pediatric Infectious Diseases, 2nd edn. pp 1179–1187
35. Harvala H, Kalimo H, Stanway G, Hyypia T (2003) Pathogenesis of coxsackievirus A9 in mice: role of the viral arginine-glycineaspartic acid motif. J Gen Virol. Doi: 10.1099/vir.0.19246-0.
36. Kapusinszky B, Minor P, Delwart E (2012) Nearly constant shedding of diverse enteric viruses by two healthy infants. J Clin Microbiol. Doi: 10.1128/JCM.01589-12.
37. Wildenbeest JG, Benschop KS, Bouma-de Jongh S, Wolthers KC, Pajkrt D (2016) Prolonged Shedding of Human Parechovirus in Feces of Young Children After Symptomatic Infection. Pediatr Infect Dis J. doi: 10.1097/INF.0000000000001082.
38. Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R (2015) Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology. Doi: 10.1016/j.virol.2015.06.006.
39. Westerhuis BM, Koen G, Wildenbeest JG, Pajkrt D, de Jong MD, Benschop KS, Wolthers KC (2012) Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for
pathogenesis and therapy development. J Gen Virol. Doi: 10.1099/vir.0.043323-0.
40. Triantafilou K, Vakakis E, Orthopoulos G, Ahmed MA, Schumann C, Lepper PM, Triantafilou M (2005) TLR8 and TLR7 are involved in the host’s immune response to human parechovirus 1. Eur J Immunol. Doi: 10.1002/eji.200526149.
41. Volpe JJ (2008) Neonatal encephalitis and whitematter injury: more than just inflammation? Ann Neurol. doi: 10.1002/ana.21466.
42. de Crom SC, van Furth MA, Peters MF, Rossen JW, Obihara CC (2012) Characteristics of pediatric patients with enterovirus meningitis and no cerebral fluid pleocytosis. Eur J Pediatr. doi: 10.1007/s00431-011-1626-z.
43. Singer JI, Maur PR, Riley JP, Smith PB (1980) Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 96:559
44. Wilfert CM, Lehrman SN, Katz SL (1983) Enteroviruses and meningitis.
Pediatr Infect Dis 2:333 45. Rantakallio P, Leskinen M, von Wendt L (1986) Incidence and
prognosis of central nervous system infections in a birth cohort of 12,000 children. Scand J Infect Dis 18:287 46. Vollbach S, Muller A, Drexler JF, Simon A, Drosten C, Eis-Hubinger AM, Panning M (2015) Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study. Virol J. doi: 10.1186/s12985-015-0427-9.
47. Berkovich S, Pangan J (1968) Recoveries of virus from premature infants during outbreaks of respiratory disease: the relation of ECHO virus type 22 to disease of the upper and lower respiratory tract in the premature infant. Bull N YAcad Med 44:377 48. Ehrnst A, Eriksson M (1993) Epidemiological features of type 22 echovirus infection. Scand J Infect Dis 25:275
49. Wildenbeest JG, Wolthers KC, Straver B, Pajkrt D (2013) Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics. Doi: 10.1542/peds. 2012-1136.
50. Abed Y, Boivin G (2006) Human parechovirus types 1, 2 and 3 infections in Canada. Emerg Infect Dis 12:969 51. Benschop KS, Schinkel J, Minnaar RP, Pajkrt D, Spanjerberg L, Kraakman HC, Berkhout B, Zaaijer HL, Beld MG, Wolthers KC (2006) Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis 42:204 52. Harvala H, Robertson I, Chieochansin T, McWilliams Leitch EC, Templeton K, Simmonds P (2009) Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis. doi: 10.1086/599094.
53. Wolthers KC, Benschop KS, Schinkel J, Molenkamp R, Bergevoet RM, Spijkerman IJ, Kraakman HC, Pajkrt D (2008) Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin Infect Dis. doi: 10.1086/589752
54. van der Linden L, Wolthers KC, van Kuppeveld FJ (2015) Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses. Doi: 10.3390/v7082832.
55. Boivin G, Abed Y, Boucher FD (2005) Human parechovirus 3 and neonatal infections. Emerg Infect Dis. doi: 10.3201/eid1101. 040606.
56. Sainato R, Flanagan R, Mahlen S, Fairchok M, Braun L (2011) Severe human parechovirus sepsis beyond the neonatal period. J Clin Virol. Doi: 10.1016/j.jcv.2011.02.009.
57. Schuffenecker I, Javouhey E, Gillet Y, Kugener B, Billaud G, Floret D, Lina B, Morfin F (2012) Human parechovirus infections, Lyon, France, 2008–10: evidence for severe cases. J Clin Virol. doi: 10. 1016/j.jcv.2012.04.016.
58. Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ (2011) Human parechovirus 3 causing sepsis-like illness in children from Midwestern United States. Pediatr Infect DisJ. doi: 10.1097/INF.0b013e3181fbefc8.
59. Verboon-MaciolekMA, Groenendaal F, Hahn CD, Hellmann J, and van Loon AM, Boivin G, de Vries LS (2008) Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol. doi: 10.1002/ana.21445.
60. Esposito S, Bosis S, Niesters H, Principi N (2015) Enterovirus D68 Infection. Viruses. doi: 10.3390/v7112925
61. Messacar K, Schreiner TL, Maloney JA, Wallace A, Ludke J, Oberste MS, Nix WA, Robinson CC, Glode MP, Abzug MJ, Dominguez SR (2015) A cluster of acute flaccid paralysis and
cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. Doi: 10. 1016/S0140-6736(14)62457-0.
62. Chang LY, Huang LM, Gau SS,Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY (2007) Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. doi: 10.1056/NEJMoa065954
63. Andreoletti L, Blassel-Damman N, Dewilde A, Vallee L, Cremer R, Hober D,Wattre P (1998) Comparison of use of cerebrospinal fluid, serum, and throat swab specimens in diagnosis of enteroviral acute neurological infection by a rapid RNA detection PCR assay. J Clin Microbiol 36:589                    
64. Benschop K, Molenkamp R, van der Ham A, Wolthers K, Beld M (2008) Rapid detection of human parechoviruses in clinical samples by real-time PCR. J Clin Virol 41:69
65. Carroll KC, Taggart B, Robison J, Byington C, Hillyard D (2000) Evaluation of the roche AMPLICOR enterovirus PCR assay in the diagnosis of enteroviral central nervous system infections. J Clin Virol 19:149
66. Riding MH, Stewart J, Clements GB, Galbraith DN (1996) Enteroviral polymerase chain reaction in the investigation of aseptic meningitis. J Med Virol 50:204
67. Vuorinen T, Vainionpaa R, Hyypia T (2003) Five years’ experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin Infect Dis. doi: 10.1086/376635
68. Yerly S, Gervaix A, Simonet V, Caflisch M, Perrin L, Wunderli W (1996) Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J Clin Microbiol 34:199
69. de Crom SC, Obihara CC, de Moor RA, Veldkamp EJ, van Furth AM, Rossen JW (2013) Prospective comparison of the detection rates of human enterovirus and parechovirus RT-qPCR and viral culture in different pediatric specimens. J Clin Virol. Doi: 10.1016/j.jcv.2013.07.017.
70. Nix WA, Maher K, Johansson ES, Niklasson B, Lindberg AM, Pallansch MA, Oberste MS (2008) Detection of all known parechoviruses by real-time PCR. J Clin Microbiol. Doi: 10.1128/JCM.00277-08.
71. Nix WA, Oberste MS, Pallansch MA (2006) Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 44:2698
72. Li R, Liu L,Mo Z,Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, Jiang L, Dong C, Che Y, Huang T, Jiang Z, Xie Z,Wang L, LiaoY, Liang Y, NongY, Liu J, Zhao H, Na R, Guo L, Pu J,Yang E, Sun L, Cui P, ShiH, Wang J, LiQ (2014)An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. doi: 10.1056/NEJMoa1303224.
73. Zhu F, XuW, Xia J, Liang Z, Liu Y, Zhang X, Tan X,Wang L, Mao Q,Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J,Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N (2014) Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. doi: 10.1056/NEJMoa1304923.
74. Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, Hu YM, Wu X, Liu P, Zhu LY, Gao F, Jin H, Chen YJ, Dong YY, Liang YC, Shi NM, Ge HM, Liu L, Chen SG,
Ai X, Zhang ZY, Ji YG, Luo FJ, Chen XQ, Zhang Y, Zhu LW, Liang ZL, Shen XL (2013) Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in
China: a multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet. doi: 10.1016/S0140-6736(13)61049-1.
75. Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA (1995) Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis 20:1201
76. Nagington J (1982) Echovirus 11 infection and prophylactic antiserum. Lancet 1:446
77. Wildenbeest JG, van den Broek PJ, Benschop KS, Koen G, Wierenga PC, Vossen AC, Kuijpers TW, Wolthers KC (2012) Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility. Antivir Ther. Doi: 10.3851/IMP1936.
78. Yen MH, Huang YC, Chen MC, Liu CC, Chiu NC, Lien R, Chang LY, Chiu CH, Tsao KC, Lin TY (2015) Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration. J Clin Virol. Doi: 10.1016/j.jcv.2015.01.013.
79. Abzug MJ, Cloud G, Bradley J, Sanchez PJ, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberlin DW, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2003) Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. doi: 10.1097/01.inf.0000059765. 92623.70.
80. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ (2006) Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 50:2409
81. Rotbart HA, Webster AD, Pleconaril Treatment Registry Group (2001) Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32:228
82. Abzug MJ, Michaels MG, Wald E, Jacobs RF, Romero JR, Sanchez PJ, Wilson G, Krogstad P, Storch GA, Lawrence R, Shelton M, Palmer A, Robinson J, Dennehy P, Sood SK, Cloud G, Jester P, Acosta EP, Whitley R, Kimberlin D, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2016) A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. J Pediatric Infect Dis Soc. doi: 10.1093/jpids/piv015.
83. Sells CJ, Carpenter RL, Ray CG (1975) Sequelae of central nervous-system enterovirus infections. N Engl J Med. doi: 10.1056/NEJM197507032930101.
84. Wilfert CM, Thompson RJ Jr, Sunder TR, O’Quinn A, Zeller J, Blacharsh J (1981) Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics
67:811
85. Verboon-Maciolek MA, Groenendaal F, Cowan F, Govaert P, van Loon AM, de Vries LS (2006) White matter damage in neonatal enterovirus meningoencephalitis. Neurology. Doi: 10.1212/01.wnl.
0000208429.69676.23.